跳至主要内容
临床试验/NCT02839603
NCT02839603终止不适用

Asymptomatic Leishmania Infection and Burden of Visceral Leishmaniasis in HIV-infected Individuals in North West Ethiopia: a Pilot Study

Institute of Tropical Medicine, Belgium1 个研究点 分布在 1 个国家目标入组 540 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
540
试验地点
1
主要终点
The proportion of individuals with L.donovani asymptomatic infection at baseline in HIV coinfected adults enrolled in HIV care in a VL-HIV endemic region in North-West Ethiopia.

研究概览

简要总结

To collect pilot data on the prevalence and incidence of asymptomatic Leishmania donovani infection in HIV infected individuals in a visceral leishmaniasis (VL)-HIV endemic region to inform the feasibility of a larger study exploring a screen and treat strategy for VL in HIV co-infected individuals in East-Africa (Ethiopia).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV infection
  • without a history of VL in the last 5 years
  • stable residents of a VL-endemic area
  • willing to participate and giving free informed consent

排除标准

  • younger than 18 years

结局指标

主要结局

The proportion of individuals with L.donovani asymptomatic infection at baseline in HIV coinfected adults enrolled in HIV care in a VL-HIV endemic region in North-West Ethiopia.

时间窗: End of study (2 years)

Proportion of individuals with asymptomatic infection, defined as positivity on any of the leishmanial markers (PCR, urine antigen or serology)

次要结局

  • Proportion of asymptomatic infected patients in clinical determinant groups.(End of study (2 years))
  • Proportion of baseline asymptomatic infected patients, with positive infection status for each baseline leishmanial marker at 3, 6, 9 and 12 months(3, 6, 9 and 12 months of follow-up)
  • Total proportion of baseline asymptomatic infected patients, with positive infection status at 3, 6, 9 and 12 months follow-up.(3, 6, 9 and 12 months of follow-up)
  • The proportion of individuals with asymptomatic infection during follow-up in HIV coinfected adults enrolled in HIV care in a VL-HIV endemic region in North-West Ethiopia(End of study (2 years))
  • Proportion of individuals developing VL within the following year (= One-year risk of VL)(End of study (2 years))
  • Proportions of individuals with a positive test on a specific leishmanial marker to describe the pattern of asymptomatic infection.(End of study (2 years))

研究者

发起方
Institute of Tropical Medicine, Belgium
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验